Sponsored by

Office of Biological and Environmental Research,
The Department of Energy
in cooperation with

The National Institute for Occupational Safety and Health, and

The National Jewish Medical and Research Center

June 25, 2002

Welcome!

On behalf of the planning committee, welcome to the Beryllium Research Symposium: Basic Mechanisms and Human Health. This meeting represents an exciting opportunity to bring new and established researchers in beryllium disease together with those from related areas of science.

Chronic Beryllium Disease presents a unique research opportunity—an occupational lung disease for which we have exposure data, clinical data, and a known hapten. While the immunological underpinnings of the disease have been identified, the molecular and cellular events underlying progression from sensitization to granulomatous disease have yet to be elucidated. Determination of these events is critical to reduction of disease risk and development of therapeutic interventions. This is the challenge we bring to you today.

Thank you for joining us in the presentation of your research, the exchange of ideas, and the development beryllium-related collaborations.

 

Sincerely,

Sally Tinkle, National Institute for Occupational Safety and Health

Lee Newman, National Jewish Medical and Research Center

Lisa Maier, National Jewish Medical and Research Center

Beryllium Research Symposium Planning Committee